Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
CN
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

38th ACS National Medicinal Chemistry Symposium (NMCS Seattle 2024)

2024-05-19
|
Page View:

1.png

38th ACS National Medicinal Chemistry Symposium
For four days, Seattle will be the setting of a high-profile and international scientific meeting. The scientific program will be composed of six sessions presenting hot topics and emerging trends in medicinal chemistry and drug discovery.


Medicilon is a global integrated pharmaceutical R&D service contract research organization (CRO), providing a full range of one-stop preclinical R&D services, in compliance with Chinese and international regulatory filing standards, to pharmaceutical companies and research institutions world-wide. Our comprehensive suite of expert services covers the entire process of preclinical new drug research, including drug discovery, pharmacology and toxicology preclinical research. As of April 2024, Medicilon has proudly served over 2000 clients worldwide, contributing to the successful approval of over 400 IND applications in China and over 70 INDs overseas, demonstrating our commitment to providing high-quality services and supporting the global advancement of pharmaceutical development.


Medicilon offers comprehensive drug discovery services, including medicinal and synthetic chemistry alongside biology expertise. We help pharmaceutical, biotech, and academic researchers overcome challenges in discovering and optimizing small molecule drug candidates.

In the early stages, companies often leverage the FTE model to synthesize structural fragments and candidate compounds, accelerating drug screening. Medicilon provides all-encompassing chemistry research services across all project stages, with both FFS and FTE models for your flexibility.


We extensively utilize cutting-edge drug discovery technologies like AI, PROTAC, and ADC technology to efficiently advance your projects, control costs, and ensure superior quality.
Date: June 23-26, 2024
Location: Seattle, WA, United States
Medicilon Booth #1

Meet with Medicilon
Subject丨NMCS Seattle 2024

Share:
Return
Relevant newsRelevant news